{
    "clinical_study": {
        "@rank": "58733", 
        "arm_group": [
            {
                "arm_group_label": "Topical IBU twice daily", 
                "arm_group_type": "Experimental"
            }, 
            {
                "arm_group_label": "Placebo twice daily", 
                "arm_group_type": "Placebo Comparator"
            }, 
            {
                "arm_group_label": "Topical IBU three times daily", 
                "arm_group_type": "Experimental"
            }, 
            {
                "arm_group_label": "Placebo three times daily", 
                "arm_group_type": "Placebo Comparator"
            }
        ], 
        "brief_summary": {
            "textblock": "This study is being conducted to evaluate the effects of IBU 5% Topical Gel versus topical\n      placebo for the relief of pain associated with a first  or second degree ankle sprain.  Both\n      twice daily and three times daily regimens will be evaluated."
        }, 
        "brief_title": "5% Topical Ibuprofen (IBU) for Ankle Sprain", 
        "completion_date": {
            "#text": "September 2014", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Ankle Injuries", 
            "Sprains and Strains"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Sprains and Strains", 
                "Ankle Injuries", 
                "Wounds and Injuries"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  First or second degree ankle sprain within 48 hours of first dose of study medication\n\n          -  Medically cleared to participate\n\n        Exclusion Criteria:\n\n          -  Similar injury of same joint within last 6 months\n\n          -  Requires bed rest, surgery, or over-the-counter or prescription analgesics"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "12 Years"
        }, 
        "enrollment": {
            "#text": "340", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "June 21, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01945034", 
            "org_study_id": "B3491009"
        }, 
        "intervention": [
            {
                "arm_group_label": "Topical IBU twice daily", 
                "description": "Topical gel administered as 4 inch strip twice daily for 7 days, and as needed for an additional 3 days", 
                "intervention_name": "Topical IBU twice daily", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Placebo twice daily", 
                "description": "Topical gel administered as a 4 inch strip twice daily for 7 days, and as needed for an additional 3 days", 
                "intervention_name": "Placebo twice daily", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Topical IBU three times daily", 
                "description": "Topical gel administered as a 4 inch strip three times daily for 7 days, and as needed for additional 3 days", 
                "intervention_name": "Topical IBU three times daily", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Placebo three times daily", 
                "description": "Topical gel administered as a 4 inch strip three times daily for 7 days, and as needed for additional 3 days", 
                "intervention_name": "Placebo three times daily", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Ibuprofen"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "topical ibuprofen", 
            "ankle sprain"
        ], 
        "lastchanged_date": "May 14, 2014", 
        "link": {
            "description": "To obtain contact information for a study center near you, click here.", 
            "url": "https://trialinfoemail.pfizer.com/pages/landing.aspx?StudyID=B3491009&StudyName=5%25%20Topical%20Ibuprofen%20%28IBU%29%20for%20Ankle%20Sprain"
        }, 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Sheffield", 
                        "country": "United States", 
                        "state": "Alabama", 
                        "zip": "35660"
                    }, 
                    "name": "Pfizer Investigational Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Tucson", 
                        "country": "United States", 
                        "state": "Arizona", 
                        "zip": "85712"
                    }, 
                    "name": "Pfizer Investigational Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Anaheim", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "92801"
                    }, 
                    "name": "Pfizer Investigational Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Carmichael", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "95608"
                    }, 
                    "name": "Pfizer Investigational Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Fair Oaks", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "95628"
                    }, 
                    "name": "Pfizer Investigational Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "La Mesa", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "91942"
                    }, 
                    "name": "Pfizer Investigational Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "National City", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "91950"
                    }, 
                    "name": "Pfizer Investigational Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Oceanside", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "92056"
                    }, 
                    "name": "Pfizer Investigational Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "San Diego", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "92120"
                    }, 
                    "name": "Pfizer Investigational Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Miami", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "33130"
                    }, 
                    "name": "Pfizer Investigational Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Miami", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "33144"
                    }, 
                    "name": "Pfizer Investigational Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "South Miami", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "33143"
                    }, 
                    "name": "Pfizer Investigational Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Blackfoot", 
                        "country": "United States", 
                        "state": "Idaho", 
                        "zip": "83221"
                    }, 
                    "name": "Pfizer Investigational Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Metairie", 
                        "country": "United States", 
                        "state": "Louisiana", 
                        "zip": "70006"
                    }, 
                    "name": "Pfizer Investigational Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Omaha", 
                        "country": "United States", 
                        "state": "Nebraska", 
                        "zip": "68134"
                    }, 
                    "name": "Pfizer Investigational Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Omaha", 
                        "country": "United States", 
                        "state": "Nebraska", 
                        "zip": "68114"
                    }, 
                    "name": "Pfizer Investigational Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Salisbury", 
                        "country": "United States", 
                        "state": "North Carolina", 
                        "zip": "28144"
                    }, 
                    "name": "Pfizer Investigational Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Fargo", 
                        "country": "United States", 
                        "state": "North Dakota", 
                        "zip": "58103"
                    }, 
                    "name": "Pfizer Investigational Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Houston", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "77074"
                    }, 
                    "name": "Pfizer Investigational Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Houston", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "77098"
                    }, 
                    "name": "Pfizer Investigational Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Houston", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "77062"
                    }, 
                    "name": "Pfizer Investigational Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "San Antonio", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "78240"
                    }, 
                    "name": "Pfizer Investigational Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "San Antonio", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "78229"
                    }, 
                    "name": "Pfizer Investigational Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Sugar Land", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "77479"
                    }, 
                    "name": "Pfizer Investigational Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Webster", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "77598"
                    }, 
                    "name": "Pfizer Investigational Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Danville", 
                        "country": "United States", 
                        "state": "Virginia", 
                        "zip": "24541"
                    }, 
                    "name": "Pfizer Investigational Site"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "4", 
        "official_title": "Placebo-controlled, Double-blind Evaluation of the Efficacy and Safety of Ibuprofen 5% Topical Gel for the Treatment of Ankle Sprain", 
        "overall_contact": {
            "last_name": "Pfizer CT.gov Call Center", 
            "phone": "1-800-718-1021"
        }, 
        "overall_official": {
            "affiliation": "Pfizer", 
            "last_name": "Pfizer CT.gov Call Center", 
            "role": "Study Director"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "September 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "measure": "Sum of pain intensity difference on weight bearing over 24 hours after first dose", 
                "safety_issue": "No", 
                "time_frame": "24 hours"
            }, 
            {
                "measure": "Sum of pain intensity difference on weight bearing over 3 days", 
                "safety_issue": "No", 
                "time_frame": "3 days"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01945034"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Sum of pain intensity difference at rest over 24 hours", 
                "safety_issue": "No", 
                "time_frame": "24 hours"
            }, 
            {
                "measure": "Subject Global Assessment of Ankle Injury", 
                "safety_issue": "No", 
                "time_frame": "Days 3 and 10"
            }, 
            {
                "measure": "Physician Global Assessment of Ankle Injury", 
                "safety_issue": "No", 
                "time_frame": "Days 3 and 10"
            }, 
            {
                "measure": "Ankle Pain at Rest", 
                "safety_issue": "No", 
                "time_frame": "Each post-dose time point through 7 days"
            }, 
            {
                "measure": "Ankle Pain Upon Weight Bearing", 
                "safety_issue": "No", 
                "time_frame": "Each post-dose timepoing through 7 days"
            }, 
            {
                "measure": "Time weighted sum of pain intensity difference at rest", 
                "safety_issue": "No", 
                "time_frame": "Over 6 hours on Day 1 and over 2 hours on Day 3"
            }, 
            {
                "measure": "Time weighted sum of pain intensity difference upon weight bearing", 
                "safety_issue": "No", 
                "time_frame": "Over 6 hours on Day 1 and over 2 hours on Day 3"
            }, 
            {
                "measure": "Time weighted pain intensity difference score", 
                "safety_issue": "No", 
                "time_frame": "Over each day, over 3 days, over 7 days"
            }, 
            {
                "measure": "Subject assessment of normal function and activity", 
                "safety_issue": "No", 
                "time_frame": "Days 3 and 10"
            }, 
            {
                "measure": "Subject Global Assessment of Medication", 
                "safety_issue": "No", 
                "time_frame": "Day 10"
            }, 
            {
                "measure": "Time to onset of first perceptible relief", 
                "safety_issue": "No", 
                "time_frame": "First 6 hours after Dose 1"
            }, 
            {
                "measure": "Time to onset of meaningful relief", 
                "safety_issue": "No", 
                "time_frame": "First 6 hours after Dose 1"
            }, 
            {
                "measure": "Time to rescue medication after initial dose, and after each subsequent dose provided that at least 25% of subjects take rescue medication", 
                "safety_issue": "No", 
                "time_frame": "10 days"
            }, 
            {
                "measure": "Number of doses of rescue medication used", 
                "safety_issue": "No", 
                "time_frame": "First 7 days of dosing"
            }, 
            {
                "measure": "Percentage of subjects taking rescue medication", 
                "safety_issue": "No", 
                "time_frame": "10 days"
            }
        ], 
        "source": "Pfizer", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Pfizer", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "September 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}